References

  1. Béji S, Kaaroud H, Ben Moussa F, Goucha R, Abderrahim E, El Younsi F, Ben Maïz H. Amylose rénale compliquant l’évolution de colites inflammatoires chroniques. Presse Med. 2004 Jul 31;33(13):862-5. Google Scholar

  2. Wendling D, Humbert P, Hory B, Blanc D, Dupond JL, Guidet M. Le rein de la maladie de Still de l’adulte. Rev Rhum Mal Osteoartic. 1989 Mar 15;56(4):325-7.

  3. Harrington TM, Moran JJ, Davis DE. Amyloidosis in adult onset Still’s disease. J Rheumatol. 1981 Sep-Oct;8(5):833-6.

  4. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H et al. Preliminary criteria for classification of adult still’s disease. J Rheumatol. 1992 Mar;19(3):424-30. PubMed | Google Scholar

  5. Katia Stankovic, Gilles Grateau. Amylose AA. Néphrologie & Thérapeutique. 2008 Jul;4(4):281-7.

  6. Vigneron AM, Kaplan G, Labrouse C, Leroux-Roret C, Réné E, Kahn MF. Amylose au cours de la maladie de Still de l’adulte: à propos de deux observations. Ann Med Int. 1986;137(5):406-8.

  7. Ben Ghorbel I, Khanfir M, Houman MH. Amylose rénale compliquant une maladie de Still de l’adulte. Rev Med Int. 2004 Sep;25(9):675-7. PubMed | Google Scholar

  8. Kchir MM, Abid F, Hajri R, Abdelmoula L, Ben Moussa F, Zouari R. Amylose au cours de la maladie de Still de l’adulte: intérêt du traitement par cyclophosphamide. Ann Med Interne. 1998 Dec;149(8):527-9.

  9. Ohta A, Yamaguchi M, Tsunematsu T, Kasukawa R, Mizushima H, Kashiwagi H et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol. 1990 Aug;17(8):1058-63. PubMed | Google Scholar

  10. Cabane J, Michon A, Ziza JM, Bourgois P, Blétry O, Godeau P et al. Comparison of long term evolution of adult onset and Still’s disease, both followed-up for more than ten years. Ann Rheum Dis. 1990 May;49(5):283-5. Google Scholar

  11. Tejera B, Martínez-Morillo M, Holgado S, Olivé A. Secondary amyloidosis in adult onset Still's disease. Med Clin (Barc). 2014 Jul 22;143(2):92-3. PubMed | Google Scholar

  12. Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007 Jun 7;356(23):2361-71. PubMed | Google Scholar

  13. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001 Jul 7;358(9275):24-9. PubMed | Google Scholar

  14. Fatihi E, Ramdani B, Fadel H, Hachim K, Zahiri K, Benghanem GM et al. Prévalence des lésions amyloïdes sous-cutanées, labiale et rectale chez des patients ayant une amylose rénale confirmée histologiquement. Néphrologie. 2000;21(1):19-21. Google Scholar

  15. Ortiz-Santamaria V, Olive A, Valls-Roc M, Tena X. Treatment of AA amyloid with Chlorambucil. Rheumatology (Oxford). 2002;41:833. PubMed | Google Scholar

  16. Chevrel G, Jenvrin C, McGregor B, Miossec P. Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology (Oxford). 2001;40:821-5. Google Scholar

  17. Fernández-Nebro A, Olivé A, Castro MC, Varela AH, Riera E, Irigoyen MV et al. Long-term TNF alpha blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. Am J Med. 2010;123(5):454-61. PubMed | Google Scholar

  18. Serratrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med. 2003;115(7):589-90. PubMed | Google Scholar

  19. Fernandez-Nebro A, Tomero E, Ortiz-Santamaria V, Castro MC, Olive A, De Haro M et al. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med. 2005;118:552-6. Google Scholar

  20. Kishida D, Okuda Y, Onishi M, Takebayashi M, Matoba K, Jouyama K et al. Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic activehepatitis B and amyloid A amyloidosis. Mod Rheumatol. 2011;21(2):215-8. Google Scholar